glp 1 approved for Novo's Wegovy becomes first GLP-1 drug MASH GLP-1 Drugs: Where We Are

When Should You Contact Your Healthcare Provider

Cleveland Clinic notes that large calorie deficits can contribute to fatigue. When recovery is impaired, training performance and adaptation may be affected

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that primarily works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite

Note that a 503A pharmacy won't appear on the FDAs 503B list - that's expected, as 503A pharmacies aren't required to register with the FDA

Continue reading to learn more about tirzepatide, including a side-by-side comparison of tirzepatide vs semaglutide for PCOS